Association Between Urodynamic Findings and Urinary Retention After Onabotulinumtoxin A for Idiopathic Overactive Bladder
Neurourology and Urodynamics · 2025
DOI: 10.1002/nau.70050 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Neurourology and Urodynamics, 2025. Verfasst von Anjali Kapur und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, New York University, Langone Health, New York, New York, USA. Hauptthemen laut MEDLINE: Urinary Bladder, Overactive, Urodynamics, Botulinum Toxins, Type A, Urinary Retention. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: This secondary analysis did not receive any external sources of funding. Funding for the primary analysis which utilized the same original data set as the curr….
Abstract (Originalsprache)
Introduction
Onabotulinumtoxin A (BTX‐A) is a minimally invasive therapy for idiopathic overactive bladder (iOAB). Incomplete bladder emptying is a known risk of the procedure, with an overall rate as high as 20% in male and female patients. Risk factors for incomplete bladder emptying after BTX‐A have been reported in the literature, but are widely variable amongst studies and therefore patients at increased risk of this adverse effect cannot easily be identified by clinicians. The aim of this study was to evaluate whether pre‐procedure urodynamics (UDS) findings are associated with incomplete bladder emptying after intradetrusor BTX‐A injection for iOAB.
Methods
Data were analyzed from the SUFU Research Network (SURN) multi‐institutional retrospective database. Men and women undergoing first‐time injection of 100 units BTX‐A for iOAB in 2016 were included. Subjects were excluded if they did not have record of pre‐procedure and post‐procedure (within 1 month) post‐void residual volume (PVR). The primary outcome was incidence of urinary retention within 1 month after BTX‐A, defined as PVR > 300 mL and/or initiation of self‐catheterization or indwelling catheter. We assessed the association of pre‐procedure UDS parameters with urinary retention using Wilcoxon rank tests, Fisher's exact test, and chi‐squared tests.
Results
A total of 167 subjects (141 women, 26 men) were included. Ninety‐nine subjects (59%) had urodynamic data. Thirty‐seven subjects (22%) had urinary retention within 1 month of BTX‐A. There were no significant differences in age, gender, race, or body mass index between the retention and non‐retention groups. There was no statistically significant difference in median Qmax between those who did and did not have postprocedure retention (10.0 vs. 14.3 mL/s respectively, p = 0.06). Mean PVR at the start of UDS was not statistically significant when comparing the retention and non‐retention groups (22.5 vs. 10.0 mL respectively, p = 0.70). Bladder outlet obstruction index (BOOI), bladder contractility index (BCI), and presence of detrusor overactivity (DO) were not found to be associated with posttreatment retention.
Conclusion
This retrospective multi‐institutional cohort study revealed that of patients who receive UDS before BTX‐A, there are no significant UDS parameters or baseline demographic factors associated with incomplete bladder emptying after intradetrusor BTX‐A injections for iOAB. Future studies that focus on better defining objective evidence‐based predictors of incomplete emptying after BTX are needed to optimize patient perception of efficacy and satisfaction with this therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Urology, New York University, Langone Health, New York, New York, USA.
- Department of Urology, University of Michigan, Ann Arbor, Michigan, USA.
- Division of Urology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Virginia Mason Franciscan Health Medical Center, Seattle, Washington, USA.
- Department of Urology, University of California San Francisco, San Francisco, California, USA.
- Department of Urology, UC San Diego Health, San Diego, California, USA.
Förderung
- This secondary analysis did not receive any external sources of funding. Funding for the primary analysis which utilized the same original data set as the curr…
Zitieren
APA
Kapur, A., Van Til, M., Daignault-Newton, S., Seibel, C., Nagpal, S., Ippolito, G. M., Smith, A. L., Lucioni, A., Lee, U., Suskind, A., Anger, J., Chung, D., Reynolds, W. S., Cameron, A. P., Tenggardjaja, C., Padmanabhan, P., Brucker, B. M., & SUFU Research Network (2025). Association Between Urodynamic Findings and Urinary Retention After Onabotulinumtoxin A for Idiopathic Overactive Bladder. Neurourology and Urodynamics. https://doi.org/10.1002/nau.70050
Vancouver
Kapur A, Van Til M, Daignault-Newton S, Seibel C, Nagpal S, Ippolito GM, et al. Association Between Urodynamic Findings and Urinary Retention After Onabotulinumtoxin A for Idiopathic Overactive Bladder. Neurourology and Urodynamics. 2025. doi:10.1002/nau.70050
BibTeX
@article{Kapur2025,
author = {Kapur, Anjali and Van Til, Monica and Daignault-Newton, Stephanie and Seibel, Caitlin and Nagpal, Shavy and Ippolito, Giulia M and Smith, Ariana L and Lucioni, Alvaro and Lee, Una and Suskind, Anne and Anger, Jennifer and Chung, Doreen and Reynolds, W Stuart and Cameron, Anne P and Tenggardjaja, Christopher and Padmanabhan, Priya and Brucker, Benjamin M and SUFU Research Network, SUFU Research Network},
title = {Association Between Urodynamic Findings and Urinary Retention After Onabotulinumtoxin A for Idiopathic Overactive Bladder},
journal = {Neurourology and Urodynamics},
year = {2025},
doi = {10.1002/nau.70050}
}
EUVIMED